Organigram: Consensus Analyst Estimates For Q2 2021

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April 13th before the market open. Analysts have a consensus C$4.14 12-month price target on the company, via a total of 14 analysts, with two analysts having strong buy ratings. Two analysts meanwhile have buy ratings, nine have hold ratings and one analyst has a sell rating. The street high comes from Stifel-GMP with a C$6 price target, and the lowest target sits at C$2.

Nine analysts have revenue estimates for the second quarter. The mean between all 9 is C$20.21 million; this number has been revised downwards from C$24.51 million at the start of the year. The highest revenue estimate is C$23.87 million from Alliance Global, while the lowest is C$16 million.

Onto EBITDA estimates, there are currently eight analysts who have second-quarter EBITDA estimates. The mean is currently negative C$5.39 million, with this number having been revised down from almost breakeven at the start of the year. Street high is a negative C$4.1 million EBITDA estimate and the lowest being negative C$6.9 million.

Analysts estimate that quarterly earnings per share will come in at negative C$0.03, with this number being slightly revised down from negative C$0.02 at the start of the year. Street high is negative C$0.01 and the lowest estimate is negative C$0.05 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Altamira Gold Encounters Porphyritic Intrusive Rocks In Initial Scout Drilling At Regional Targets

Related News

Psyched Wellness: Canaccord Pens “Future In Fungi Report”

Yesterday morning, Canaccord Genuity released a primer into five psychedelic companies that they “believe could...

Tuesday, March 9, 2021, 11:49:00 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM

Roku: Analysts Expect Positive Net Income For Q2 2021

Roku Inc (NASDAQ: ROKU) will be reporting its second quarter financial results after the market...

Wednesday, August 4, 2021, 03:10:00 PM

DraftKings: Canaccord Lowers Estimates Based On Planned Future Reinvestment

DraftKings Inc. (Nasdaq: DKNG) earlier this month announced its third-quarter financial results. The company announced...

Sunday, November 20, 2022, 06:29:00 PM

BMO Reiterates $10 Price Target On Kinross Gold Following Russian Asset Sale

On April 5th, Kinross Gold (TSX: K) announced the sale of its Russian assets, with...

Saturday, April 9, 2022, 03:03:00 PM